全文获取类型
收费全文 | 528171篇 |
免费 | 5137篇 |
国内免费 | 928篇 |
专业分类
电工技术 | 9650篇 |
综合类 | 640篇 |
化学工业 | 82112篇 |
金属工艺 | 23954篇 |
机械仪表 | 17737篇 |
建筑科学 | 11564篇 |
矿业工程 | 4428篇 |
能源动力 | 11731篇 |
轻工业 | 38676篇 |
水利工程 | 6306篇 |
石油天然气 | 15301篇 |
武器工业 | 34篇 |
无线电 | 56443篇 |
一般工业技术 | 113767篇 |
冶金工业 | 84880篇 |
原子能技术 | 15603篇 |
自动化技术 | 41410篇 |
出版年
2021年 | 4660篇 |
2019年 | 4510篇 |
2018年 | 8328篇 |
2017年 | 8462篇 |
2016年 | 8893篇 |
2015年 | 5208篇 |
2014年 | 9095篇 |
2013年 | 22855篇 |
2012年 | 13704篇 |
2011年 | 17826篇 |
2010年 | 14231篇 |
2009年 | 16170篇 |
2008年 | 16657篇 |
2007年 | 16351篇 |
2006年 | 13962篇 |
2005年 | 12662篇 |
2004年 | 12472篇 |
2003年 | 12118篇 |
2002年 | 11782篇 |
2001年 | 11835篇 |
2000年 | 11412篇 |
1999年 | 11157篇 |
1998年 | 23681篇 |
1997年 | 17771篇 |
1996年 | 13840篇 |
1995年 | 11006篇 |
1994年 | 10101篇 |
1993年 | 10057篇 |
1992年 | 8102篇 |
1991年 | 8013篇 |
1990年 | 8000篇 |
1989年 | 7785篇 |
1988年 | 7531篇 |
1987年 | 6807篇 |
1986年 | 6832篇 |
1985年 | 7695篇 |
1984年 | 7180篇 |
1983年 | 6847篇 |
1982年 | 6254篇 |
1981年 | 6484篇 |
1980年 | 6208篇 |
1979年 | 6331篇 |
1978年 | 6371篇 |
1977年 | 6943篇 |
1976年 | 8424篇 |
1975年 | 5701篇 |
1974年 | 5663篇 |
1973年 | 5727篇 |
1972年 | 4967篇 |
1971年 | 4501篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
S Arold P Franken MP Strub F Hoh S Benichou R Benarous C Dumas 《Canadian Metallurgical Quarterly》1997,5(10):1361-1372
BACKGROUND: Human immunodeficiency virus (HIV) Nef protein accelerates virulent progression of acquired immunodeficiency syndrome (AIDS) by its interaction with specific cellular proteins involved in signal transduction and host cell activation. Nef has been shown to bind specifically to a subset of the Src family of kinases. The structures of free Nef and Nef bound to Src homology region 3 (SH3) domain are important for the elucidation of how the affinity and specificity for the Src kinase family SH3 domains are achieved, and also for the development of potential drugs and vaccines against AIDS. RESULTS: We have determined the crystal structures of the conserved core of HIV-1 Nef protein alone and in complex with the wild-type SH3 domain of the p59fyn protein tyrosine kinase (Fyn), at 3.0 A resolution. Comparison of the bound and unbound Nef structures revealed that a proline-rich motif (Pro-x-x-Pro), which is implicated in SH3 binding, is partially disordered in the absence of the binding partner; this motif only fully adopts a left-handed polyproline type II helix conformation upon complex formation with the Fyn SH3 domain. In addition, the structures show how an arginine residue (Arg77) of Nef interacts with Asp 100 of the so-called RT loop within the Fyn SH3 domain, and triggers a hydrogen-bond rearrangement which allows the loop to adapt to complement the Nef surface. The Arg96 residue of the Fyn SH3 domain is specifically accommodated in the same hydrophobic pocket of Nef as the isoleucine residue of a previously described Fyn SH3 (Arg96-->lle) mutant that binds to Nef with higher affinity than the wild type. CONCLUSIONS: The three-dimensional structures support evidence that the Nef-Fyn complex forms in vivo and may have a crucial role in the T cell perturbating action of Nef by altering T cell receptor signaling. The structures of bound and unbound Nef reveal that the multivalency of SH3 binding may be achieved by a ligand induced flexibility in the RT loop. The structures suggest possible targets for the design of inhibitors which specifically block Nef-SH3 interactions. 相似文献
992.
MG Tucci G Ricotti R Giardino S Carraro G Mattei I Cataldi G Lucarini R Solmi L Tosi G Biagini 《Canadian Metallurgical Quarterly》1997,43(8):1213-1220
Establishing guidelines and experimental models preclinical and clinical evaluations of new agents for treatment, and/or prevention of human diseases has become a task of crucial importance. Psoriasis is such one disease holding great interest for dermatology owing to its high rate of incidence and complexity of treatment. However the absence of psoriatic lesions in animals and the inability to induce them, calls for experimental techniques both in vitro and in vivo. The purpose of this study was to evaluate experimentally the effects of tacalcitol on cell proliferation and differentiation process. Thereafter a human pilot study on psoriatic patients has been developed. 相似文献
993.
994.
Sampled-data techniques are used to examine the dynamic characteristics and closed-loop performance of the quasi-square-wave boost converter. Direct duty-ratio control and current-mode control are considered. With direct duty-ratio control, the system poles remain well damped under all load conditions, and there is no zero in the control-to-output transfer function. Good closed-loop performance is therefore achieved. Under current-mode control, the requirement for a stabilizing ramp is seen to depend on load conditions, and the achievable voltage control-loop bandwidth is smaller than that using direct duty-ratio control; however, there is a significant reduction in the magnitude of the DC source to output-voltage frequency response 相似文献
995.
SM Kornblau E Estey T Madden HT Tran S Zhao U Consoli V Snell G Sanchez-Williams H Kantarjian M Keating RA Newman M Andreeff 《Canadian Metallurgical Quarterly》1997,15(5):1796-1802
PURPOSE: Expression of the multidrug resistance gene (MDR1) p170 protein is frequent in leukemic blasts from patients with relapsed acute myelogenous leukemia (AML). A phase I study using the nonimmunosuppressive MDR1 blocker SDZ PSC-833 (PSC) in combination with mitoxantrone (MITO) and etoposide (VP) was performed. PATIENTS AND METHODS: Starting doses (LVL0) of MITO (3.25 mg/m2/d on days 1 and 3 to 6) and VP (210 mg/m2/d on days 1 and 3 to 5) were 40% of the maximal-tolerated dose (MTD) from a prior study. A 1.5-mg/kg loading dose of PSC was followed by a 120-hour continuous infusion of 10 mg/kg/d on days 2 to 6. Blood samples for PSC, MITO, and VP pharmacokinetics (PK) were taken on days 1 and 3, and samples for MDR1 expression were taken on day 0. RESULTS: Severe mucositis developed in all patients at LVL0; therefore, MITO and VP doses were reduced to 2.5 and 170 mg/m2 (LVL-1) for the next seven patients, and this dose proved to be MTD. All LVL0 and three LVL-1 patients had transient elevations in the serum bilirubin level to > or = 4 mg/dL. Serum creatinine level increased to greater than 2 mg/dL in one case. There were no other grade 3 or 4 nonhematologic toxicities observed. The peripheral blood was cleared of leukemia in three LVL0 and four LVL-1 patients. The marrow was cleared of leukemic cells in one LVL0 and five LVL-1 patients, and a significant reduction in marrow leukemic infiltrate was observed in eight of 10. No patient achieved complete remission (CR), and all died of progressive disease (n = 8) or infection (n = 2). MDR1 expression was detected by fluorescent-activated cell sorter (FACS) analysis in five of seven cases. An elevated MDR1 mRNA level was detected by quantitative polymerase chain reaction (Q-PCR) in six of eight cases studied. Clearing of leukemia cells from the marrow occurred in four of six MDR1-positive and one of three MDR1-negative patients. Despite the fact that LVL0 doses had to be reduced due to toxicity, coadministration of PSC did not produce a consistent effect on MITO PK; however, it did repeatedly lead to increased levels of VP in the serum. CONCLUSION: We conclude that PSC-MITO-VP is a tolerable regimen with antileukemic activity. Addition of PSC necessitated a 66% reduction in MITO and VP doses from a prior study without PSC. 相似文献
996.
The MnO activities in (MnO-CrO
x
-CaO-SiO2)-containing melts, which were saturated with the (Mn, Cr)3O4 spinel phase, were determined at 1500 °C under an oxygen partial pressure of 10−8.99 atm. This was done by equilibrating the samples with platinum. The activity of MnO in the melt was then calculated from the
activity coefficient of manganese in the resultant Pt-Cr-Mn alloy. Darken’s quadratic formalism for ternary metallic solutions
was used to calculate the activity coefficient of manganese in the Pt-Cr-Mn system, in which platinum was considered to be
the solvent. It was found that an increase in the concentration of MnO in the melt increases both the MnO activity and the
activity coefficient of MnO. For a constant MnO concentration in the (MnO-CrO
x
-CaO-SiO2)-containing melts, the activity of MnO can be increased by increasing the basicity of the melt. In order to obtain high-manganese
recoveries from (MnO-CrO
x
-CaO-SiO2)-containing melts into an alloy phase, basic slags in which the activity coefficient of MnO is high should therefore be used. 相似文献
997.
A Serrano Pascual C Merino Hernáez R Ochoa Mejías A Escolano Chamois J Golbano Ablanque I Otero Tejero M Sanz Redondo F Román Ruiz 《Canadian Metallurgical Quarterly》1997,21(6):631-635
BACKGROUND AND AIMS OF THE STUDY: Surgical treatment of functional tricuspid regurgitation associated with advanced valvular disease remains controversial, mainly due to the difficulty in choosing between valve replacement or reconstructive surgery. Failure to correct tricuspid regurgitation during valvular surgery carries a poor prognosis, as reoperation may represent a significant risk to the patient. Thus correct tricuspid valve surgery is vital to achieve improved early and long-term clinical results. METHODS: A total of 142 patients underwent concomitant tricuspid annuloplasty with mitral valve replacement and their clinical outcome was assessed. RESULTS: Overall hospital mortality rate was 11.3%. Seven patients died during follow up. The overall actuarial survival rate for 10 years was 74.1 +/- 14.2%. Postoperatively, 75.8% of the patients had no residual tricuspid insufficiency, while 24.2% had first- or second-degree tricuspid insufficiency and were treated medically. All patients were in NHYA functional class I or II postoperatively. CONCLUSION: Clinically, it is important to assess the severity of functional tricuspid insufficiency before and/or during the operation. Bicuspidalization annuloplasty for functional tricuspid insufficiency has provided good results, with a low incidence of reoperation and significant clinical improvement. The technique could be used in most patients with functional tricuspid regurgitation. 相似文献
998.
999.
G Raviv JP Vanegas M Petein C Schulman A Danguy R Kiss E Wespes 《Canadian Metallurgical Quarterly》1997,158(5):1778-1782
PURPOSE: The objectives of this study were to quantify the immunohistochemical stainings of collagen types I, III and IV, and investigate the value of glycohistochemical staining with 3 lectin types specific to a particular glycan structure, Arachis hypogaea, Triticum vulgare and concanavalin A, as a method of defining possible changes in the collagen structure of the tunica albuginea in potent and impotent patients. MATERIALS AND METHODS: The study involved 4 normal men, 4 with pure venous leakage and 4 with pure arterial disease. Collagen types I, III and IV, and lectins Arachis hypogaea, Triticum vulgare and concanavalin A were studied using a cell image processor. The labeling index relates to the percentage of staining and mean optical density relates to the staining intensity. RESULTS: Mean labeling index values for the 3 types of collagen and lectins were similar (p > 0.05). Mean optical density value relating to collagen type I was significantly higher in the arteriogenic group than in the other groups (p < 0.05), while mean optical density value of collagen type IV was significantly higher in the venogenic group than in the 2 other groups (p < 0.05). Mean optical density values relating to the 3 lectin types were similar in the 3 clinical groups (p > 0.05). CONCLUSIONS: An alteration in the distribution and structure of the various collagen types and lectins in the tunica albuginea of impotent patients has been shown that may interfere with normal function and lead to impotence. 相似文献
1000.
G Cardinali V Vollenbroich MS Jeon AA de Graaf CP Hollenberg 《Canadian Metallurgical Quarterly》1997,17(3):1722-1730
The induction process of the galactose regulon has been intensively studied, but until now the nature of the inducer has remained unknown. We have analyzed a delta gal7 mutant of the yeast Kluyveromyces lactis, which lacks the galactotransferase activity and is able to express the genes of the Gal/Lac regulon also in the absence of galactose. We found that this expression is semiconstitutive and undergoes a strong induction during the stationary phase. The gal1-209 mutant, which has a reduced kinase activity but retains its positive regulatory function, also shows a constitutive expression of beta-galactosidase, suggesting that galactose is the inducer. A gal10 deletion in delta gal7 or gal1-209 mutants reduces the expression to under wild-type levels. The presence of the inducer could be demonstrated in both delta gal7 crude extracts and culture medium by means of a bioassay using the induction in gal1-209 cells. A mutation in the transporter gene LAC12 decreases the level of induction in gal7 cells, indicating that galactose is partly released into the medium and then retransported into the cells. Nuclear magnetic resonance analysis of crude extracts from delta gal7 cells revealed the presence of 50 microM galactose. We conclude that galactose is the inducer of the Gal/Lac regulon and is produced via UDP-galactose through a yet-unknown pathway. 相似文献